MHRA0026440_003 - Appendix to Committee on Safety of Medicines SubCommittee on Safety Efficacy and Adverse Reactions

Appendix to Committee on Safety of Medicines SubCommittee on Safety Efficacy and Adverse Reactions 10 July 1992 Advised product licence should be granted for Baxter Recombinate